Guangzhou LBP Medicine Science & Technology Co., Ltd.
SHH: 688393.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Xiangting Cai
- Employees
- 907
- Headquarters
- Guangzhou, China
- IPO year
- 2020
- Market cap
- CN¥2.4B
- Website
- https://www.gzlbp.com
Loading 688393…
Loading profile data…Frequently asked questions about 688393
What does Guangzhou LBP Medicine Science & Technology Co., Ltd. (688393.SS) do?
Guangzhou LBP Medicine Science & Technology Co., Ltd. engages in the research, development, and production of pathological diagnosis products in China. It offers pathological diagnostic reagents and ancillary equipment, including liquid-based cytology, such as gynecological series, non-gynecological series, and equipment; fluorescence in situ hy...
Where does 688393.SS trade?
Guangzhou LBP Medicine Science & Technology Co., Ltd. (688393.SS) trades on the Shanghai Stock Exchange.
What sector is 688393.SS in?
Guangzhou LBP Medicine Science & Technology Co., Ltd. (688393.SS) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Guangzhou LBP Medicine Science & Technology Co., Ltd.?
Xiangting Cai is the chief executive officer of Guangzhou LBP Medicine Science & Technology Co., Ltd. (688393.SS).
Where is Guangzhou LBP Medicine Science & Technology Co., Ltd. headquartered?
Guangzhou LBP Medicine Science & Technology Co., Ltd. is headquartered in China.
Does 688393.SS pay a dividend?
Yes — Guangzhou LBP Medicine Science & Technology Co., Ltd. (688393.SS) paid a trailing twelve-month dividend of CNY 0.10 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 688393.SS go public?
Guangzhou LBP Medicine Science & Technology Co., Ltd. (688393.SS) completed its initial public offering in 2020.